SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 5.22 |
| Enterprise Value ($M) | 2.05 |
| Book Value ($M) | 3.68 |
| Book Value / Share | 0.24 |
| Price / Book | 1.42 |
| NCAV ($M) | 1.71 |
| NCAV / Share | 0.11 |
| Price / NCAV | 3.06 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.58 |
| Return on Assets (ROA) | -1.41 |
| Return on Equity (ROE) | -2.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.72 |
| Current Ratio | 1.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.78 |
| Assets | 6.75 |
| Liabilities | 3.07 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 | ||
| 13G/A | Nikko Asset Management Americas, Inc. | 0.00 | -100.00 | |
| 13G/A | Sumitomo Mitsui Trust Holdings, Inc. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,792 | 92,415 | 5.19 | |
| 14,586 | 135,042 | 10.80 | |
| 16,911 | 63,426 | 26.66 | |
| 13,149 | 44,843 | 29.32 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OKYO – OKYO Pharma Limited | ONCO – Onconetix, Inc. |
| ONCY – Oncolytics Biotech Inc. | ORGO – Organogenesis Holdings Inc. |
| ORMP – Oramed Pharmaceuticals Inc. |